Study: Triple-drug protocol safe, effective for preventing clots

03/26/2012 | CardiologyToday.com

Adding cilostazol to a dual-antiplatelet treatment protocol of aspirin and clopidogrel is as safe and effective as a double-dose dual protocol for preventing blood clots in angioplasty patients, according to a study presented at a cardiology meeting. After a month, serious bleeding, cardiovascular-related death, myocardial infarction or stroke was seen in 1.2% of triple therapy patients, compared with 1.4% of patients receiving double-dose dual therapy. The trial will monitor patients for three more years.

View Full Article in:

CardiologyToday.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Sr Manager, Business Conduct
Gilead Sciences
Foster City, CA
Chief Executive Officer
UCare Minnesota
Minneapolis, MN